ProMIS Neurosciences is trading 6% down today at $11.90 as the stock undergoes a technical pullback following a sharp multi-day rebound.
- The decline follows a significant double-digit surge on July 17, with the stock selling off over the past three sessions as the recent rally loses momentum.
- No fresh company-specific news or regulatory events have been reported, suggesting the move is driven by traders unwinding volatility-driven gains rather than a new fundamental catalyst.
- The current price action indicates a technical correction as the market stabilizes from the previous week's price fluctuations.